• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性乳腺癌和原位乳腺癌的安全切缘是多少?

What are safe margins of resection for invasive and in situ breast cancer?

机构信息

Lynn Sage Comprehensive Breast Center and Department ofSurgery, Feinberg School of Medicine of Northwestern University, Chicago, Illinois 60614, USA.

出版信息

Oncology (Williston Park). 2011 Sep;25(10):890-5.

PMID:22010383
Abstract

Adequate surgical margins in breast-conserving surgery are an important predictor of local recurrence (LR) rates. The definition of tumor-free margins in National Surgical Adjuvant Breast and Bowel Project (NSABP) trials requires that tumor cells do not touch ink, but subsequent retrospective single-institution studies have suggested that wider margins confer greater protection against LR. Particularly wide margins have been proposed for ductal carcinoma in situ. However, wider margin requirements lead to higher re-excision rates, with attendant economic, psychological, and cosmetic costs, and perhaps increased mastectomy rates. Juxtaposed against these concerns about optimal margin width, a meta-analysis of clinical trials has demonstrated the survival value of minimizing LR. We are therefore at a juncture where a reduction of LR may be achieved by tumor resection with wide margins, but data regarding optimal margin width are conflicting and the risk/benefit balance of tumorectomy with wide margins has not been demonstrated. A randomized trial of reexcision for close margins inserted into trials of systemic therapy could be considered but seems unlikely. Alternatively, detailed longitudinal data need to balance the value and the cost of wide margins. Until better data are available, the desirable margin width will vary depending on individual circumstances, including age, histology, and patient preference.

摘要

保乳手术中的充分手术切缘是局部复发 (LR) 率的一个重要预测因素。国家外科辅助乳腺和肠道项目 (NSABP) 试验中肿瘤无切缘的定义要求肿瘤细胞不能接触墨,但随后的回顾性单机构研究表明,更宽的切缘提供了对 LR 更大的保护。特别是宽的切缘已被提议用于导管原位癌。然而,更宽的切缘要求导致更高的再次切除率,随之而来的是经济、心理和美容方面的成本,以及可能增加的乳房切除术率。在考虑这些关于最佳切缘宽度的担忧的同时,临床试验的荟萃分析证明了最小化 LR 的生存价值。因此,我们正处于一个通过广泛切缘的肿瘤切除术来降低 LR 的关键时刻,但关于最佳切缘宽度的数据存在冲突,广泛切缘的肿瘤切除术的风险/获益平衡尚未得到证明。在系统治疗试验中插入密切切缘的再次切除术随机试验可以考虑,但似乎不太可能。或者,需要详细的纵向数据来平衡广泛切缘的价值和成本。在更好的数据可用之前,理想的切缘宽度将根据个体情况而有所不同,包括年龄、组织学和患者偏好。

相似文献

1
What are safe margins of resection for invasive and in situ breast cancer?浸润性乳腺癌和原位乳腺癌的安全切缘是多少?
Oncology (Williston Park). 2011 Sep;25(10):890-5.
2
Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?术中触摸准备细胞学检查;它在再切除乳房肿块切除术中起作用吗?
Ann Surg Oncol. 2007 Mar;14(3):1045-50. doi: 10.1245/s10434-006-9263-x. Epub 2007 Jan 6.
3
Close/positive margins after breast-conserving therapy: additional resection or no resection?保乳治疗后切缘阳性/切缘接近:是否再次切除?
Breast. 2013 Aug;22 Suppl 2:S115-7. doi: 10.1016/j.breast.2013.07.022.
4
Breast conservation and negative margins: how much is enough?保乳手术和阴性切缘:多少才算足够?
Breast. 2009 Oct;18 Suppl 3:S84-6. doi: 10.1016/S0960-9776(09)70279-6.
5
Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.接受乳腺癌保乳手术的女性术中手术切缘状态大体检查的准确性。
Am Surg. 2005 Jan;71(1):22-7; discussion 27-8.
6
Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision?在乳房肿瘤切除术时增加切除边缘是否可以避免再次切除的需要?
Am J Surg. 2008 Oct;196(4):556-8. doi: 10.1016/j.amjsurg.2008.06.007.
7
The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.保乳手术治疗乳腺癌后,再次切除切缘阳性组织在优化局部疾病控制方面的作用。
Breast J. 2006 Jul-Aug;12(4):331-7. doi: 10.1111/j.1075-122X.2006.00271.x.
8
[Margin status in invasive breast cancer].[浸润性乳腺癌的切缘状态]
Bull Cancer. 2008 Dec;95(12):1161-70. doi: 10.1684/bdc.2008.0766.
9
Who should not undergo breast conservation?哪些人不适合进行保乳治疗?
Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021.
10
Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?乳腺原位癌患者在最终手术切缘处局部复发的风险:是否需要再次切除?
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):726-30. doi: 10.1016/j.ijrobp.2013.08.012. Epub 2013 Sep 21.

引用本文的文献

1
The clinical usefulness of optical coherence tomography during cancer interventions.光学相干断层扫描在癌症介入治疗中的临床应用。
J Cancer Res Clin Oncol. 2018 Oct;144(10):1967-1990. doi: 10.1007/s00432-018-2690-9. Epub 2018 Jun 20.
2
Reporting the margin in pancreaticoduodenectomies: R0 versus R1.胰十二指肠切除术中切缘的报告:R0与R1
Indian J Gastroenterol. 2017 Mar;36(2):81-87. doi: 10.1007/s12664-017-0742-8. Epub 2017 Apr 18.
3
Safe negative margin width in breast conservative therapy: results from a population with a high percentage of negative prognostic factors.
保乳治疗中安全切缘宽度:具有高比例不良预后因素人群的研究结果
World J Surg. 2014 Nov;38(11):2863-70. doi: 10.1007/s00268-014-2651-7.
4
Influence of surgical margins on the outcome of breast cancer patients: a retrospective analysis.手术切缘对乳腺癌患者预后的影响:一项回顾性分析。
World J Surg. 2014 Sep;38(9):2279-87. doi: 10.1007/s00268-014-2596-x.
5
Extent of primary breast cancer surgery: standards and individualized concepts.原发性乳腺癌手术范围:标准与个体化理念
Breast Care (Basel). 2012 Oct;7(5):364-9. doi: 10.1159/000343976.
6
Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?HER2 扩增型乳腺癌旁正常组织中的基因组异常:是癌变区域还是污染的肿瘤细胞?
Breast Cancer Res Treat. 2012 Dec;136(3):693-703. doi: 10.1007/s10549-012-2290-3. Epub 2012 Oct 27.
7
Ductal carcinoma in situ of the breast: a surgical perspective.乳腺导管原位癌:外科视角
Int J Surg Oncol. 2012;2012:761364. doi: 10.1155/2012/761364. Epub 2012 Sep 4.